Cargando…

Role of Epigenetics in Type 2 Diabetes and Obesity

Epigenetic marks the genome by DNA methylation, histone modification or non-coding RNAs. Epigenetic marks instruct cells to respond reversibly to environmental cues and keep the specific gene expression stable throughout life. In this review, we concentrate on DNA methylation, the mechanism often as...

Descripción completa

Detalles Bibliográficos
Autores principales: Capparelli, Rosanna, Iannelli, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393970/
https://www.ncbi.nlm.nih.gov/pubmed/34440181
http://dx.doi.org/10.3390/biomedicines9080977
_version_ 1783743845301747712
author Capparelli, Rosanna
Iannelli, Domenico
author_facet Capparelli, Rosanna
Iannelli, Domenico
author_sort Capparelli, Rosanna
collection PubMed
description Epigenetic marks the genome by DNA methylation, histone modification or non-coding RNAs. Epigenetic marks instruct cells to respond reversibly to environmental cues and keep the specific gene expression stable throughout life. In this review, we concentrate on DNA methylation, the mechanism often associated with transgenerational persistence and for this reason frequently used in the clinic. A large study that included data from 10,000 blood samples detected 187 methylated sites associated with body mass index (BMI). The same study demonstrates that altered methylation results from obesity (OB). In another study the combined genetic and epigenetic analysis allowed us to understand the mechanism associating hepatic insulin resistance and non-alcoholic disease in Type 2 Diabetes (T2D) patients. The study underlines the therapeutic potential of epigenetic studies. We also account for seemingly contradictory results associated with epigenetics.
format Online
Article
Text
id pubmed-8393970
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83939702021-08-28 Role of Epigenetics in Type 2 Diabetes and Obesity Capparelli, Rosanna Iannelli, Domenico Biomedicines Review Epigenetic marks the genome by DNA methylation, histone modification or non-coding RNAs. Epigenetic marks instruct cells to respond reversibly to environmental cues and keep the specific gene expression stable throughout life. In this review, we concentrate on DNA methylation, the mechanism often associated with transgenerational persistence and for this reason frequently used in the clinic. A large study that included data from 10,000 blood samples detected 187 methylated sites associated with body mass index (BMI). The same study demonstrates that altered methylation results from obesity (OB). In another study the combined genetic and epigenetic analysis allowed us to understand the mechanism associating hepatic insulin resistance and non-alcoholic disease in Type 2 Diabetes (T2D) patients. The study underlines the therapeutic potential of epigenetic studies. We also account for seemingly contradictory results associated with epigenetics. MDPI 2021-08-08 /pmc/articles/PMC8393970/ /pubmed/34440181 http://dx.doi.org/10.3390/biomedicines9080977 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Capparelli, Rosanna
Iannelli, Domenico
Role of Epigenetics in Type 2 Diabetes and Obesity
title Role of Epigenetics in Type 2 Diabetes and Obesity
title_full Role of Epigenetics in Type 2 Diabetes and Obesity
title_fullStr Role of Epigenetics in Type 2 Diabetes and Obesity
title_full_unstemmed Role of Epigenetics in Type 2 Diabetes and Obesity
title_short Role of Epigenetics in Type 2 Diabetes and Obesity
title_sort role of epigenetics in type 2 diabetes and obesity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393970/
https://www.ncbi.nlm.nih.gov/pubmed/34440181
http://dx.doi.org/10.3390/biomedicines9080977
work_keys_str_mv AT capparellirosanna roleofepigeneticsintype2diabetesandobesity
AT iannellidomenico roleofepigeneticsintype2diabetesandobesity